Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms | 64 | 2023 | 21683 | 4.000 |
Why?
|
Gastrointestinal Neoplasms | 15 | 2023 | 990 | 2.970 |
Why?
|
Palliative Care | 26 | 2023 | 3493 | 2.480 |
Why?
|
Pancreatic Neoplasms | 16 | 2022 | 5256 | 2.200 |
Why?
|
Quality of Life | 32 | 2023 | 12804 | 1.640 |
Why?
|
Cost of Illness | 10 | 2022 | 1859 | 1.450 |
Why?
|
Terminal Care | 10 | 2023 | 1694 | 1.360 |
Why?
|
Hospitalization | 19 | 2023 | 10262 | 1.300 |
Why?
|
Sarcopenia | 4 | 2023 | 368 | 1.260 |
Why?
|
Adenocarcinoma | 8 | 2024 | 6364 | 1.090 |
Why?
|
Patient Participation | 7 | 2021 | 1457 | 1.080 |
Why?
|
Clinical Trials as Topic | 7 | 2023 | 7913 | 0.980 |
Why?
|
Medical Oncology | 6 | 2023 | 2265 | 0.950 |
Why?
|
Geriatrics | 2 | 2021 | 396 | 0.940 |
Why?
|
Lung Neoplasms | 13 | 2022 | 13102 | 0.900 |
Why?
|
Patient Acceptance of Health Care | 6 | 2023 | 3022 | 0.830 |
Why?
|
Carcinoma, Pancreatic Ductal | 6 | 2021 | 1634 | 0.830 |
Why?
|
Adaptation, Psychological | 7 | 2018 | 2576 | 0.830 |
Why?
|
Aged | 83 | 2023 | 163280 | 0.820 |
Why?
|
Camptothecin | 2 | 2015 | 576 | 0.810 |
Why?
|
Caregivers | 8 | 2021 | 2094 | 0.730 |
Why?
|
Depression | 13 | 2021 | 7766 | 0.670 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2022 | 5221 | 0.660 |
Why?
|
Humans | 144 | 2024 | 744343 | 0.660 |
Why?
|
Electronics | 1 | 2020 | 322 | 0.630 |
Why?
|
Health Care Costs | 5 | 2020 | 3209 | 0.630 |
Why?
|
Neoadjuvant Therapy | 6 | 2024 | 2728 | 0.630 |
Why?
|
Patient Selection | 5 | 2023 | 4215 | 0.630 |
Why?
|
Hematology | 1 | 2021 | 221 | 0.610 |
Why?
|
SEER Program | 7 | 2023 | 1508 | 0.610 |
Why?
|
Informed Consent | 2 | 2021 | 995 | 0.600 |
Why?
|
Patient Readmission | 4 | 2024 | 3114 | 0.600 |
Why?
|
Personal Satisfaction | 1 | 2022 | 643 | 0.590 |
Why?
|
Hospice Care | 6 | 2023 | 672 | 0.580 |
Why?
|
Aged, 80 and over | 35 | 2023 | 57776 | 0.570 |
Why?
|
Colorectal Neoplasms | 7 | 2023 | 6773 | 0.570 |
Why?
|
Financing, Personal | 1 | 2019 | 308 | 0.560 |
Why?
|
Esophageal Neoplasms | 2 | 2024 | 1583 | 0.550 |
Why?
|
Carboxylesterase | 1 | 2015 | 31 | 0.530 |
Why?
|
Monitoring, Ambulatory | 1 | 2019 | 355 | 0.530 |
Why?
|
Affect | 4 | 2020 | 1476 | 0.530 |
Why?
|
Male | 81 | 2023 | 350118 | 0.520 |
Why?
|
Middle Aged | 62 | 2023 | 213383 | 0.510 |
Why?
|
Female | 86 | 2023 | 380194 | 0.500 |
Why?
|
Body Composition | 3 | 2021 | 2401 | 0.490 |
Why?
|
Geriatric Assessment | 3 | 2023 | 1372 | 0.480 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2023 | 11524 | 0.480 |
Why?
|
Survivors | 5 | 2021 | 2291 | 0.480 |
Why?
|
Prognosis | 23 | 2023 | 29063 | 0.460 |
Why?
|
Physician-Patient Relations | 4 | 2020 | 3229 | 0.460 |
Why?
|
Health Services Accessibility | 5 | 2021 | 5137 | 0.460 |
Why?
|
Travel | 1 | 2019 | 788 | 0.440 |
Why?
|
Hospitals, Special | 1 | 2013 | 101 | 0.430 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2024 | 4034 | 0.420 |
Why?
|
Pancreatectomy | 1 | 2017 | 804 | 0.410 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.410 |
Why?
|
Leucovorin | 5 | 2022 | 628 | 0.410 |
Why?
|
Conflict of Interest | 1 | 2016 | 544 | 0.400 |
Why?
|
Inpatients | 2 | 2022 | 2518 | 0.400 |
Why?
|
Activities of Daily Living | 2 | 2019 | 2418 | 0.390 |
Why?
|
Drug Industry | 1 | 2016 | 746 | 0.370 |
Why?
|
Fluorouracil | 6 | 2022 | 1619 | 0.370 |
Why?
|
Income | 2 | 2019 | 1913 | 0.370 |
Why?
|
Antineoplastic Agents | 8 | 2021 | 13695 | 0.360 |
Why?
|
Muscle, Skeletal | 4 | 2021 | 4931 | 0.360 |
Why?
|
Insurance Coverage | 5 | 2021 | 1901 | 0.360 |
Why?
|
Length of Stay | 6 | 2023 | 6309 | 0.350 |
Why?
|
Adult | 39 | 2024 | 214055 | 0.340 |
Why?
|
Antiemetics | 2 | 2020 | 177 | 0.330 |
Why?
|
Chemokines | 1 | 2013 | 970 | 0.330 |
Why?
|
Anxiety | 9 | 2022 | 4297 | 0.310 |
Why?
|
Self Report | 4 | 2022 | 3558 | 0.310 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2018 | 1209 | 0.310 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2734 | 0.310 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2023 | 1596 | 0.310 |
Why?
|
Cross-Sectional Studies | 17 | 2023 | 25043 | 0.300 |
Why?
|
Healthcare Disparities | 3 | 2021 | 3158 | 0.300 |
Why?
|
Registries | 3 | 2021 | 8089 | 0.290 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2838 | 0.280 |
Why?
|
Cachexia | 2 | 2020 | 204 | 0.280 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.270 |
Why?
|
Medicare | 5 | 2020 | 6566 | 0.260 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3674 | 0.260 |
Why?
|
Analgesics | 1 | 2012 | 1040 | 0.260 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15540 | 0.260 |
Why?
|
Telemedicine | 2 | 2021 | 2872 | 0.260 |
Why?
|
Communication | 2 | 2019 | 3749 | 0.250 |
Why?
|
End Stage Liver Disease | 2 | 2019 | 314 | 0.250 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2690 | 0.250 |
Why?
|
Goals | 2 | 2020 | 706 | 0.250 |
Why?
|
Age Factors | 8 | 2023 | 18370 | 0.240 |
Why?
|
Treatment Outcome | 8 | 2023 | 63114 | 0.240 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2021 | 1381 | 0.240 |
Why?
|
Life Style | 1 | 2015 | 3835 | 0.230 |
Why?
|
Current Procedural Terminology | 1 | 2024 | 92 | 0.220 |
Why?
|
Patient Care Planning | 2 | 2020 | 921 | 0.220 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2022 | 3523 | 0.220 |
Why?
|
Quality Assurance, Health Care | 1 | 2013 | 2212 | 0.210 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3923 | 0.210 |
Why?
|
Decision Making | 4 | 2021 | 3887 | 0.210 |
Why?
|
Neoplasm Metastasis | 6 | 2020 | 4851 | 0.210 |
Why?
|
Pilot Projects | 3 | 2020 | 8324 | 0.200 |
Why?
|
Psychometrics | 4 | 2019 | 3002 | 0.200 |
Why?
|
Coronary Vasospasm | 1 | 2022 | 88 | 0.200 |
Why?
|
Burkitt Lymphoma | 1 | 2023 | 327 | 0.190 |
Why?
|
Immunotherapy | 5 | 2022 | 4445 | 0.190 |
Why?
|
Survival Rate | 10 | 2023 | 12788 | 0.190 |
Why?
|
Health Care Surveys | 2 | 2018 | 2453 | 0.190 |
Why?
|
Aging | 2 | 2019 | 8664 | 0.190 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 4266 | 0.190 |
Why?
|
Nausea | 2 | 2020 | 673 | 0.190 |
Why?
|
Hypercalcemia | 1 | 2023 | 409 | 0.180 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7659 | 0.180 |
Why?
|
Health Expenditures | 5 | 2021 | 2348 | 0.180 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.180 |
Why?
|
Vomiting | 2 | 2020 | 636 | 0.180 |
Why?
|
Young Adult | 11 | 2023 | 56430 | 0.180 |
Why?
|
Veterans | 1 | 2013 | 2519 | 0.170 |
Why?
|
Ambulatory Care | 2 | 2021 | 2708 | 0.170 |
Why?
|
Retrospective Studies | 21 | 2024 | 77449 | 0.170 |
Why?
|
Prescriptions | 1 | 2022 | 387 | 0.170 |
Why?
|
Breast Neoplasms | 7 | 2023 | 20822 | 0.170 |
Why?
|
Patient Preference | 3 | 2020 | 890 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2022 | 9959 | 0.160 |
Why?
|
Videoconferencing | 1 | 2021 | 195 | 0.160 |
Why?
|
Cancer Care Facilities | 1 | 2021 | 402 | 0.160 |
Why?
|
Reproduction | 1 | 2023 | 668 | 0.160 |
Why?
|
Minority Groups | 2 | 2023 | 1223 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6538 | 0.160 |
Why?
|
International Classification of Diseases | 1 | 2024 | 867 | 0.160 |
Why?
|
Pain | 2 | 2015 | 4986 | 0.160 |
Why?
|
Cytokines | 1 | 2013 | 7322 | 0.160 |
Why?
|
Insurance, Health | 4 | 2021 | 2494 | 0.160 |
Why?
|
Carcinoma, Large Cell | 1 | 2018 | 113 | 0.160 |
Why?
|
Intensive Care Units | 3 | 2023 | 3679 | 0.160 |
Why?
|
Veterans Health | 1 | 2019 | 216 | 0.160 |
Why?
|
United States | 13 | 2021 | 69872 | 0.150 |
Why?
|
Neoplasm Staging | 5 | 2019 | 11031 | 0.150 |
Why?
|
Bile Duct Neoplasms | 1 | 2023 | 567 | 0.150 |
Why?
|
Cholangiocarcinoma | 1 | 2023 | 516 | 0.150 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7785 | 0.150 |
Why?
|
Telephone | 1 | 2021 | 617 | 0.150 |
Why?
|
Lymphoma, Follicular | 1 | 2021 | 435 | 0.150 |
Why?
|
Anorexia | 2 | 2015 | 161 | 0.150 |
Why?
|
Losartan | 1 | 2019 | 299 | 0.150 |
Why?
|
Massachusetts | 3 | 2019 | 8663 | 0.150 |
Why?
|
Stress, Psychological | 4 | 2021 | 4245 | 0.150 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2017 | 25 | 0.150 |
Why?
|
Prescription Fees | 1 | 2018 | 146 | 0.150 |
Why?
|
Vulnerable Populations | 1 | 2023 | 687 | 0.150 |
Why?
|
Siblings | 2 | 2018 | 854 | 0.140 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 973 | 0.140 |
Why?
|
Financial Support | 1 | 2016 | 115 | 0.140 |
Why?
|
Anus Neoplasms | 1 | 2020 | 332 | 0.140 |
Why?
|
Patient Discharge | 2 | 2020 | 3313 | 0.140 |
Why?
|
Family | 2 | 2017 | 3147 | 0.140 |
Why?
|
Psychological Tests | 1 | 2018 | 651 | 0.130 |
Why?
|
Counseling | 1 | 2023 | 1523 | 0.130 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8642 | 0.130 |
Why?
|
Resuscitation Orders | 1 | 2017 | 269 | 0.130 |
Why?
|
Terminally Ill | 1 | 2017 | 238 | 0.130 |
Why?
|
Prospective Studies | 11 | 2023 | 53288 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2023 | 1041 | 0.120 |
Why?
|
Attitude to Death | 1 | 2017 | 382 | 0.120 |
Why?
|
Gastroenterology | 1 | 2021 | 536 | 0.120 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39050 | 0.120 |
Why?
|
DNA, Neoplasm | 1 | 2019 | 1758 | 0.120 |
Why?
|
Attitude | 1 | 2019 | 776 | 0.120 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 503 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9239 | 0.120 |
Why?
|
Fatigue | 3 | 2020 | 1531 | 0.110 |
Why?
|
Organoplatinum Compounds | 1 | 2015 | 408 | 0.110 |
Why?
|
Aromatase Inhibitors | 1 | 2017 | 491 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1378 | 0.110 |
Why?
|
Research | 1 | 2021 | 1999 | 0.110 |
Why?
|
Consultants | 1 | 2012 | 53 | 0.110 |
Why?
|
Tumor Burden | 1 | 2018 | 1915 | 0.110 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5319 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1061 | 0.110 |
Why?
|
Blood Vessels | 1 | 2018 | 1125 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1681 | 0.110 |
Why?
|
Nursing Homes | 1 | 2019 | 1036 | 0.110 |
Why?
|
Managed Care Programs | 1 | 2018 | 950 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1076 | 0.100 |
Why?
|
Delphi Technique | 1 | 2015 | 778 | 0.100 |
Why?
|
Professional-Patient Relations | 1 | 2017 | 737 | 0.100 |
Why?
|
Liver Neoplasms | 2 | 2020 | 4253 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1206 | 0.100 |
Why?
|
Advance Care Planning | 1 | 2019 | 662 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2021 | 5078 | 0.100 |
Why?
|
Employment | 1 | 2018 | 1132 | 0.100 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13989 | 0.100 |
Why?
|
Health Status Disparities | 1 | 2023 | 1797 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2023 | 12354 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2488 | 0.090 |
Why?
|
Sexual Behavior | 1 | 2020 | 2057 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1411 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1405 | 0.090 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2018 | 941 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1425 | 0.090 |
Why?
|
Mental Health Services | 1 | 2021 | 1643 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2622 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2020 | 2266 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3396 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1956 | 0.080 |
Why?
|
Frail Elderly | 1 | 2013 | 693 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2214 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2019 | 2119 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2020 | 3279 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6459 | 0.080 |
Why?
|
Logistic Models | 3 | 2020 | 13408 | 0.080 |
Why?
|
Karnofsky Performance Status | 2 | 2020 | 173 | 0.080 |
Why?
|
Magnesium | 1 | 2011 | 813 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3597 | 0.070 |
Why?
|
Health Surveys | 1 | 2017 | 4037 | 0.070 |
Why?
|
Child | 5 | 2023 | 77709 | 0.070 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2011 | 370 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6038 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2951 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2425 | 0.070 |
Why?
|
Glucose Intolerance | 1 | 2011 | 577 | 0.070 |
Why?
|
Adolescent | 5 | 2023 | 85781 | 0.070 |
Why?
|
Social Support | 1 | 2016 | 2118 | 0.070 |
Why?
|
Hospices | 2 | 2020 | 265 | 0.070 |
Why?
|
Lymphatic Metastasis | 3 | 2018 | 2924 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5255 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2015 | 2585 | 0.060 |
Why?
|
Postural Balance | 1 | 2009 | 620 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5034 | 0.060 |
Why?
|
Emotions | 1 | 2016 | 2661 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3610 | 0.060 |
Why?
|
Poverty | 1 | 2016 | 2660 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2541 | 0.060 |
Why?
|
Health Status | 1 | 2017 | 4034 | 0.060 |
Why?
|
Quality of Health Care | 2 | 2021 | 4371 | 0.060 |
Why?
|
Body Weight | 1 | 2014 | 4669 | 0.060 |
Why?
|
Data Collection | 1 | 2013 | 3341 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2017 | 5317 | 0.060 |
Why?
|
Glioma | 1 | 2018 | 3401 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2013 | 1831 | 0.050 |
Why?
|
Carcinoembryonic Antigen | 1 | 2023 | 349 | 0.050 |
Why?
|
Walking | 1 | 2009 | 1180 | 0.050 |
Why?
|
Exercise Test | 1 | 2009 | 2074 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 295 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.050 |
Why?
|
Mutation | 3 | 2021 | 29786 | 0.050 |
Why?
|
Nitrates | 1 | 2022 | 265 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.050 |
Why?
|
Oncology Service, Hospital | 1 | 2020 | 57 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20129 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2043 | 0.050 |
Why?
|
Gene Expression | 1 | 2013 | 7799 | 0.050 |
Why?
|
Hematologic Tests | 1 | 2021 | 240 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2020 | 224 | 0.040 |
Why?
|
Pharmacies | 1 | 2021 | 150 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3616 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2022 | 15295 | 0.040 |
Why?
|
Transportation of Patients | 1 | 2020 | 185 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2021 | 802 | 0.040 |
Why?
|
Health Planning Guidelines | 1 | 2019 | 163 | 0.040 |
Why?
|
Pneumonia, Aspiration | 1 | 2019 | 145 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2013 | 4043 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2022 | 690 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5510 | 0.040 |
Why?
|
Physicians | 1 | 2016 | 4567 | 0.040 |
Why?
|
Dehydration | 1 | 2019 | 234 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3749 | 0.040 |
Why?
|
New England | 1 | 2020 | 1022 | 0.040 |
Why?
|
Antacids | 1 | 2017 | 99 | 0.040 |
Why?
|
Enzyme Replacement Therapy | 1 | 2017 | 78 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2011 | 3864 | 0.040 |
Why?
|
Comorbidity | 2 | 2023 | 10388 | 0.040 |
Why?
|
Drugs, Generic | 1 | 2021 | 421 | 0.040 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2020 | 360 | 0.040 |
Why?
|
Perioperative Care | 1 | 2024 | 1002 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 711 | 0.030 |
Why?
|
Cultural Competency | 1 | 2019 | 289 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 733 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1020 | 0.030 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 350 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2023 | 2765 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2023 | 1524 | 0.030 |
Why?
|
Waiting Lists | 1 | 2019 | 692 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3479 | 0.030 |
Why?
|
Radiotherapy | 1 | 2021 | 1533 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10252 | 0.030 |
Why?
|
Hospital Costs | 1 | 2020 | 985 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11124 | 0.030 |
Why?
|
Time Factors | 3 | 2020 | 40075 | 0.030 |
Why?
|
Drug Costs | 1 | 2021 | 1105 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2019 | 804 | 0.030 |
Why?
|
Perception | 1 | 2020 | 1198 | 0.030 |
Why?
|
Urinary Tract Infections | 1 | 2019 | 788 | 0.030 |
Why?
|
Cohort Studies | 3 | 2023 | 40561 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15226 | 0.030 |
Why?
|
Radiation Injuries | 1 | 2020 | 1180 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1580 | 0.030 |
Why?
|
Tamoxifen | 1 | 2017 | 981 | 0.030 |
Why?
|
Qualitative Research | 1 | 2021 | 2682 | 0.030 |
Why?
|
Family Health | 1 | 2016 | 1282 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1147 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 20947 | 0.020 |
Why?
|
Hypertension | 1 | 2011 | 8480 | 0.020 |
Why?
|
Constipation | 1 | 2015 | 546 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2017 | 980 | 0.020 |
Why?
|
Body Mass Index | 2 | 2021 | 12720 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2009 | 211 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1003 | 0.020 |
Why?
|
Obesity | 1 | 2011 | 12745 | 0.020 |
Why?
|
Syndrome | 1 | 2014 | 3251 | 0.020 |
Why?
|
Pneumonia | 1 | 2019 | 2133 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1547 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9849 | 0.020 |
Why?
|
Dyspnea | 1 | 2015 | 1303 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3952 | 0.020 |
Why?
|
Waist Circumference | 1 | 2011 | 917 | 0.020 |
Why?
|
Cause of Death | 1 | 2017 | 3584 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4468 | 0.020 |
Why?
|
Hand Strength | 1 | 2009 | 448 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5952 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3528 | 0.020 |
Why?
|
Sepsis | 1 | 2019 | 2593 | 0.020 |
Why?
|
Consensus | 1 | 2014 | 2959 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
Child, Preschool | 2 | 2018 | 41006 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3420 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3843 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5172 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9856 | 0.010 |
Why?
|
Gait | 1 | 2009 | 793 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5102 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
Mental Health | 1 | 2016 | 3019 | 0.010 |
Why?
|
Accidental Falls | 1 | 2009 | 1062 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6365 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3305 | 0.010 |
Why?
|
Heart Rate | 1 | 2009 | 4091 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 25625 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6256 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35136 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23338 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8554 | 0.010 |
Why?
|
Chronic Disease | 1 | 2009 | 9146 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72290 | 0.010 |
Why?
|